Influence of Mitroflow bioprosthesis structural valve deterioration on cardiac morbidity-Reference-Cited by-同舟云学术

Influence of Mitroflow bioprosthesis structural valve deterioration on cardiac morbidity

Published:2019-03-18 Issue:1 Volume:14 Page:
ISSN:1749-8090
Container-title:Journal of Cardiothoracic Surgery
language:en
Short-container-title:J Cardiothorac Surg

Author:

Waziri Farhad^ORCID,Karunanithi Zarmiga,Løgstrup Brian Bridal,Hjortdal Vibeke,Nielsen Per Hostrup,Poulsen Steen Hvitfeldt

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Surgery,Pulmonary and Respiratory Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13019-019-0875-1.pdf

Reference25 articles.

1. Yankah CA, Pasic M, Musci M, Stein J, Detschades C, Siniawski H, et al. Aortic valve replacement with the Mitroflow pericardial bioprosthesis: durability results up to 21 years. J Thorac Cardiovasc Surg. 2008;136:688–96. https://doi.org/10.1016/j.jtcvs.2008.05.022 .

2. Sjogren J, Gudbjartsson T, Thulin LI. Long-term outcome of the MitroFlow pericardial bioprosthesis in the elderly after aortic valve replacement. J Heart Valve Dis. 2006;15:197–202.

3. Johnston DR, Soltesz EG, Vakil N, Rajeswaran J, Roselli EE, Sabik JF, et al. Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants. Ann Thorac Surg. 2015;99:1239–47. https://doi.org/10.1016/j.athoracsur.2014.10.070 .

4. Minami K, Zittermann A, Schulte-Eistrup S, Koertke H, Körfer R. Mitroflow synergy prostheses for aortic valve replacement: 19 years experience with 1,516 patients. Ann Thorac Surg. 2005;80:1699–705. https://doi.org/10.1016/j.athoracsur.2005.04.053 .

5. Jamieson WRE, Koerfer R, Yankah CA, Zittermann A, Hayden RI, Ling H, et al. Mitroflow aortic pericardial bioprosthesis - clinical performance. Eur J Cardio-Thoracic Surg. 2009;36:818–24. https://doi.org/10.1016/j.ejcts.2009.05.020 .